TPL Plastech Reports 20.1% Revenue Growth to ₹1,069 Mn for Q2 FY26

TPL Plastech Limited has announced a remarkable **20.1% increase in revenue**, reaching ₹1,069 million for the quarter ending September 30, 2025. This growth is attributed to a significant **23% year-

12 November 2025
5 min read

TPL Plastech Limited has announced a remarkable 20.1% increase in revenue, reaching ₹1,069 million for the quarter ending September 30, 2025. This growth is attributed to a significant 23% year-on-year volume increase, primarily driven by the ramp-up of their new Dahej Greenfield facility and heightened market demand. The company's profitability also saw a boost, with a 27.8% rise in profit after tax, amounting to ₹69 million for the same period. TPL Plastech, a subsidiary of Time Technoplast Ltd., continues to sustain its commitment to consistent dividend payouts, maintaining an uninterrupted dividend policy for the past 18 years.

The company’s strong performance is reflected in its operational metrics, with an EBITDA margin of 11.12% for Q2 FY26, slightly up from 10.96% in the previous year. TPL Plastech's consolidated revenue for the first half of FY26 also shows a healthy 18.76% growth, totaling ₹1,973 million compared to ₹1,661.4 million in the same period last year. Key investments are planned, including ₹15 million for automation and re-engineering, alongside a shift towards green energy, which is expected to save approximately ₹4 million annually. The company aims to increase its return on capital employed (ROCE) from 20.3% to 21.0%, reflecting its focus on enhanced productivity and cost reduction.

Management highlights the shift in the industrial packaging sector towards plastics, driven by sustainability and advanced material adoption. With government initiatives to grow the sector's contribution significantly over the next few years, TPL Plastech is well-positioned to leverage increasing demand across industries like chemicals, pharmaceuticals, and logistics. The company’s strategic focus on innovation in packaging solutions aligns with a projected growth in Asian chemical production and pharmaceutical exports, potentially unlocking long-term value for stakeholders.